I don't see why big pharma would buy a 'combination' when the the trials for BTX1503 are been conducted without the use of Permetrex, if BTX1503 has patent protection - as the company claims - and the trials are being done by applying the stuff similarly to the way one puts sunscreen on, then why would they be paying for something that wasn't part of the trials?
Ann: Updated Investor Presentation, page-45
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $696.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.5¢ | 37.5¢ | $4.475M | 11.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 37310 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 54981 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |